From Medscape Neurology

Coverage from the

16th World Stroke Congress (WSC) 2024

October 23 - 26, 2024; Abu Dhabi, UAE

October 23 - 26, 2024 Abu Dhabi, UAE

Conference News

WSC 2024 Drug Combo Tied to Functional Improvement After Stroke
Medscape Medical News, October 30, 2024
WSC 2024 Thrombolysis Beneficial for ‘Eye Stroke’?
Medscape Medical News, October 30, 2024
WSC 2024 Pro-urokinase a Less Expensive Thrombolytic for Stroke
Medscape Medical News, October 30, 2024
WSC 2024 Approved Device for Stroke-Related Dysphagia Enters an RCT
Medscape Medical News, October 30, 2024
WSC 2024 New Data to Alter Planned ICH Guidelines
Medscape Medical News, October 30, 2024
WSC 2024 Extending CT Stroke Scan to the Heart Boosts Clot Detection
Medscape Medical News, October 29, 2024

WSC 2024 New Data for DOACs in Cerebral Venous Thrombosis
Medscape Medical News, October 29, 2024
WSC 2024 More Support for Early DOACs After AF-Related Stroke
Medscape Medical News, October 29, 2024
WSC 2024 Old Drug a New Option for Stroke-Related Aphasia?
Medscape Medical News, October 28, 2024
WSC 2024 New Data on DOAC Initiation After Stroke in AF: Final Word?
Medscape Medical News, October 25, 2024
WSC 2024 Uncertainty Over Balloon Guide Catheter Use for MT in Stroke
Medscape Medical News, October 25, 2024

Medscape Neurology©

Popular News From WSC 2023

No Benefit of Colchicine After Stroke, TIA: CHANCE-3 The anti-inflammatory agent, started within 24 hours of acute ischemic stroke or TIA, did not reduce subsequent stroke or other vascular events at 90 days in the CHANCE-3 trial.
Medscape Medical News, Oct 26, 2023
Oral Anticoagulation in ICH Patients With AF: New Data New information has become available to help guide clinicians on the thorny issue of whether to give oral anticoagulation to patients with AF who have had an intracranial hemorrhage.
Medscape Medical News, Oct 19, 2023
Tenecteplase Non-inferior to Alteplase in Stroke: ATTEST-2 This result, along with its ease of use, adds to the growing evidence that tenecteplase should be a first-line thrombolytic agent, trial investigators say.
Medscape Medical News, Oct 20, 2023

Previous Coverage

Related Resources

Stroke/Cerebrovascular Disease

All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.